Home > Partnering

Acquisition & In-Licensing

Strategic in-licensing and acquisitions have been fundamental to our success and will continue to drive our growth at Merus Labs. We are actively seeking new specialty pharmaceutical products in addition to continuing acquisitions of legacy products in order to strengthen our portfolio.

While we have a strong presence in Cardiovascular and Women’s Health markets, we are actively looking for prescription products in additional therapeutic areas such as Urology, CNS, Oncology Support, Dermatology, Ophthalmology, Nephrology, and Anti-Infectives. Of most interest are specialty products that are either approved or have been submitted for regulatory approval.

OUT-LICENSING

Merus Labs is seeking out-licensing partners for certain products in territories where we possess the rights but do not currently commercialize.

Contact Info

  • Geoff Morrow
    VP, Business Development
  • Kaustav Chatterjee
    Director, Business Development

For more information,

Our Acquisition & In-Licensing History

With a portfolio of 12 products, compared with two in August 2014, Merus Labs now commercializes its products in 36 countries (North America, Europe, and AsiaPac). In addition, more than one million patients around the world benefit from our products.
  • Iroko logo
    IROKO PHARMACEUTICALS
    May 11, 2012
    Acquisition of Vancocin®
  • Novartis logo
    NOVARTIS
    July 11, 2013
    Acquisition of Emselex®/Enablex®
  • Novartis logo
    NOVARTIS
    September 8, 2014
    Acquisition of Sintrom®
  • Novartis logo
    NOVARTIS
    May 22, 2015
    Acquisition of Salagen® and Estraderm®
  • UCB logo
    UCB
    February 4, 2016
    Acquisition of Elantan®, Isoket® and Deponit®
  • Sanofi logo
    SANOFI
    March 7, 2016
    Acquisition of Surgestone®, Provames®, Tredemine® and Speciafoldine®

We Are A Partner of Choice

Proven leadership in commercial launches across multiple therapeutic areas and geographies

Existing and scalable commercial infrastructure across Europe and select other markets

Strong regulatory, medical affairs and market access capabilities

Entrepreneurial culture makes Merus Labs fast, flexible, and adaptable to meet the needs of our partners